The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma
Abstract
PURPOSE: A prospective study of preoperative tumor-node-metastasis staging of patients with esophageal cancer (EC) was designed to compare the accuracy of 18-F-fluoro-deoxy-d-glucose (FDG) positron emission tomography (PET) with conventional noninvasive modalities. PATIENTS AND METHODS: Seventy-four patients with carcinomas of the esophagus (n = 43) or gastroesophageal junction (n = 31) were studied. All patients underwent attenuation-corrected FDG-PET imaging, a spiral computed tomography (CT) scan, and an endoscopic ultrasound (EUS). RESULTS: FDG-PET demonstrated increased activity in the primary tumor in 70 of 74 patients (sensitivity: 95%). False-negative PET images were found in four patients with T1 lesions. Thirty-four patients (46%) had stage IV disease. FDG-PET had a higher accuracy for diagnosing stage IV disease compared with the combination of CT and EUS (82% v 64%, respectively; P = .004). FDG-PET had additional diagnostic value in 16 (22%) of 74 patients by upstaging 11 (15%) and downstaging five (7%) patients. Thirty-nine (53%) of the 74 patients underwent a 2- or 3-field lymphadenectomy in conjunction with primary curative esophagectomy. In these patients, tumoral involvement was found in 21 local and 35 regional or distant lymph nodes (LN). For local LN, the sensitivity of FDG-PET was lower than EUS (33% v 81%, respectively; P = .027), but the specificity may have been higher (89% v 67%, respectively; P = not significant [NS]). For the assessment of regional and distant LN involvement, compared with the combined use of CT and EUS, FDG-PET had a higher specificity (90% v 98%, respectively; P = .025) and a similar sensitivity (46% v 43%, respectively; P = NS). CONCLUSION: PET significantly improves the detection of stage IV disease in EC compared with the conventional staging modalities. PET improves diagnostic specificity for LN staging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Multimodality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563664 · Cited by 4,547
Maximum Likelihood Reconstruction for Emission Tomography
Shepp, L. A., & Vardi, Y. (1982) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.1982.4307558 · Cited by 4,429
EM reconstruction algorithms for emission and transmission tomography.
Lange, K. L., & Carson, R. E. (1984) · PubMed · Cited by 1,769
Strauss, L. G. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01367602 · Cited by 527
Vansteenkiste, J. F., Stroobants, S. G., De Leyn, P. R., Dupont, P. J., Bogaert, J., Maes, A., Deneffe, G. J., Nackaerts, K. L., Verschakelen, J. A., Lerut, T. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2142 · Cited by 410
Self-citationEsophageal Carcinoma: Depth of Tumor Invasion Is Predictive of Regional Lymph Node Status
Rice, T. W., Zuccaro, G., Adelstein, D. J., Rybicki, L. A., Blackstone, E. H., & Goldblum, J. R. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)01387-8 · Cited by 362
Endoscopic ultrasound-guided fine-needle aspiration
Chang, K. J., Katz, K. D., Durbin, T. E., Erickson, R. A., Butler, J. A., Lin, F., & Wuerker, R. B. (1994) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(94)70112-1 · Cited by 341
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan, F. L., Dehdashti, F., Siegel, B. A., Trask, D. D., Sundaresan, S. R., Patterson, G. A., & Cooper, J. D. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.2.9016218 · Cited by 312
Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography
Block, M. I., Patterson, G. A., Sundaresan, R. S., Bailey, M. S., Flanagan, F. L., Dehdashti, F., Siegel, B. A., & Cooper, J. D. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00619-x · Cited by 259
(1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00974-1 · Cited by 235
Whole-body positron emission tomography: Part I. Methods and performance characteristics.
Dahlbom, M. L., Hoffman, E. J., Hoh, C. K., Schiepers, C. W., Rosenqvist, G., Hawkins, R. A., & Phelps, M. E. (1992) · PubMed · Cited by 199
Positron emission tomography for staging of oesophageal and gastroesophageal malignancy
Kole, A., Plukker, J., Nieweg, O., & Vaalburg, W. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.526 · Cited by 186
Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET.
Fukunaga, T., Okazumi, S., Koide, Y., Isono, K., & IMAZEKI, K. (1998) · PubMed · Cited by 152
The mechanism of accumulation of tumour-localising radiopharmaceuticals
Pauwels, E. K. J., McCready, V. R., Stoot, J. H. M. B., & van Deurzen, D. F. P. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050229 · Cited by 125
Hemodynamic Correlates of Outcome in Patients Undergoing Orthotopic Liver Transplantation
Nasraway, S. A., Klein, R. D., Spanier, T. B., et al. (1995) · CHEST Journal · doi:10.1378/chest.107.1.218 · Cited by 79
Likelihood ratios. Another enhancement of sensitivity and specificity.
Beck (1986) · Archives of Pathology & Laboratory Medicine · Cited by 62
Likelihood ratios. Another enhancement of sensitivity and specificity.
Beck, J. R. (1986) · PubMed · Cited by 52
Cited by
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,509
Burmeister, B. H., Smithers, B. M., Gebski, V., Fitzgerald, L., Simes, R. J., Devitt, P., Ackland, S., Gotley, D. C., Joseph, D., Millar, J., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70288-6 · Cited by 926
Rice, T. W., Patil, D. T., & Blackstone, E. H. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.03.14 · Cited by 782
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Obermannová, R., Alsina, M., Cervantes, A., Leong, T., Lordick, F., Nilsson, M., van Grieken, N. C. T., Vogel, A., & Smyth, E. C. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.003 · Cited by 730
Weber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Metadata
- Authors
- Flamen, P., Lerut, A., Van Cutsem, E., De Wever, W., Peeters, M., Stroobants, S., Dupont, P., Bormans, G., Hiele, M., De Leyn, P., Van Raemdonck, D., Coosemans, W., Ectors, N., Haustermans, K., & Mortelmans, L.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-09-18
- Volume
- 18
- Issue
- 18
- Pages
- 3202-3210
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2267741149
- Cited by
- 571
- References
- 18
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.